The neurological manifestations of long COVID‐19, including brain fog and cognitive impairment as revealed by PET imaging studies [88], may also benefit from SIRT1 activation through its neuroprotective mechanisms involving microglial regulation and mitochondrial biogenesis [89]. The gene discussed is SIRT1; the disease is COVID-19.